-
Supported By:


Subscribe or Follow
HLS Faculty & Senior Fellows
Program on Corporate Governance Advisory Board
- Peter Atkins
- David Bell
- Kerry E. Berchem
- Richard Brand
- Daniel Burch
- Paul Choi
- Jesse Cohn
- Arthur B. Crozier
- Renata J. Ferrari
- Andrew Freedman
- Ray Garcia
- Joseph Hall
- Jason M. Halper William P. Mills
- David Millstone
- Theodore Mirvis
- Philip Richter
- Elina Tetelbaum
- Sebastian Tiller
- Marc Trevino
- Steven J. Williams
Author Archives: Harvard Law School Forum on Corporate Governance and Financial Regulation
Friend or Foe? The Convergence of Private Equity and Shareholder Activism
The lines between shareholder activist strategies and traditional private equity strategies are starting to become blurred. Historically, private equity firms have adhered to the “rules of the road” set out by companies looking to explore strategic alternatives or realise monetisation events for their equity holders. The company, after approval from its board, engages a financial […]
Click here to read the complete post
Posted in Boards of Directors, Mergers & Acquisitions, Practitioner Publications, Private Equity
Tagged Boards of Directors, Buyouts, Mergers & acquisitions, Private equity, Shareholder activism, Takeover defenses
Comments Off on Friend or Foe? The Convergence of Private Equity and Shareholder Activism
Key Issues for Directors Relating to COVID-19
As the world reacts to the COVID-19 pandemic, directors on corporate boards play a vital role in navigating the path forward. Key issues facing corporate directors include: Maintaining close contact with the CEO and working with management to ensure the safety and well-being of the company’s employees and other stakeholders as well as the public […]
Click here to read the complete postHuman Capital Management Disclosure
Current law does not require much from a public company in the way of disclosing information concerning its workforce (its “human capital”) outside the C-suite or with respect to the philosophies, policies and practices it implements to select, oversee, nurture and develop that workforce (its system of “human capital management”). Under SEC disclosure requirements (Item […]
Click here to read the complete post
Posted in Accounting & Disclosure, Practitioner Publications, Securities Regulation
Tagged Compensation disclosure, Compensation ratios, Disclosure, Human capital, Regulation S-K, SEC, Securities regulation, Stakeholders, Whistleblowers
Comments Off on Human Capital Management Disclosure
Virtual Annual Meetings and Coronavirus
With rising concerns around the spread of COVID-19 (“coronavirus”) in the United States and globally, in order to mitigate health risks, many public companies may consider adding a virtual component to the format of their annual shareholder meetings. In the United States, state law generally governs the availability of a virtual meeting format. At the federal level, […]
Click here to read the complete post
Posted in Boards of Directors, Institutional Investors, Practitioner Publications
Tagged COVID-19, Engagement, Proxy advisors, Proxy voting, Risk, Shareholder meetings, State law, Virtual meetings
Comments Off on Virtual Annual Meetings and Coronavirus
Weekly Roundup: March 13-19, 2020
Joint Venture Governance Index: Calibrating the Strength of Governance in Joint Ventures Posted by James Bamford, Geoff Walker, and Martin Mogstad, Water Street Partners LLC, on Friday, March 13, 2020 Tags: Board composition, Boards of Directors, Compliance & ethics, Corporate forms, ESG, Joint ventures, Surveys A Case of Mistaken Identity: Correcting the Record on EVA Posted by Subodh Mishra, Institutional Investor Services, Inc., […]
Click here to read the complete postDiagnosing and Treating Coronavirus Risks in M&A Transactions
Novel coronavirus (COVID-19) continues to dominate headlines as confirmed cases of the virus escalate. As of March 2, 2020, the World Health Organization reported over 80,100 confirmed cases of the disease in China, and roughly another 8,800 elsewhere. These developments have led global markets to decline precipitously, local economies to suffer and governments to take […]
Click here to read the complete post
Posted in Mergers & Acquisitions, Practitioner Publications
Tagged Adverse effects, Covenants, COVID-19, Due diligence, Mergers & acquisitions, Offer pricing, Risk, Risk management
Comments Off on Diagnosing and Treating Coronavirus Risks in M&A Transactions